pyrazines has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ayturan, M; Driessen, C; Fissolo, N; Kraus, M; Overkleeft, H; Reich, M; Weissert, R | 1 |
1 other study(ies) available for pyrazines and myelin oligodendrocyte glycoprotein (35-55)
| Article | Year |
|---|---|
Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation.
Topics: Animals; Boronic Acids; Bortezomib; Brain; Cathepsins; Dipeptides; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Glycoproteins; Lymphoid Tissue; Lysosomes; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neuroglia; Neurons; NF-kappa B; Peptide Fragments; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Rats; Sulfones; T-Lymphocytes | 2008 |